Cytokinetics
CYTK
CYTK
372 hedge funds and large institutions have $7.75B invested in Cytokinetics in 2025 Q3 according to their latest regulatory filings, with 100 funds opening new positions, 123 increasing their positions, 101 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
22% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 101
20% more funds holding
Funds holding: 310 → 372 (+62)
2.46% more ownership
Funds ownership: 115.28% → 117.74% (+2.5%)
Holders
372
Holding in Top 10
16
Calls
$361M
Puts
$87.6M
Top Buyers
| 1 | +$100M | |
| 2 | +$81.2M | |
| 3 | +$78.9M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$35.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$27.5M |
Top Sellers
| 1 | -$124M | |
| 2 | -$69.7M | |
| 3 | -$63.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$41.5M |
| 5 |
O
OrbiMed
New York
|
-$35.6M |
